Your browser doesn't support javascript.
loading
Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS.
Brück, Oscar E; Lallukka-Brück, Susanna E; Hohtari, Helena R; Ianevski, Aleksandr; Ebeling, Freja T; Kovanen, Panu E; Kytölä, Soili I; Aittokallio, Tero A; Ramos, Pedro M; Porkka, Kimmo V; Mustjoki, Satu M.
Afiliação
  • Brück OE; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Lallukka-Brück SE; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Hohtari HR; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Ianevski A; Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland.
  • Ebeling FT; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Kovanen PE; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Kytölä SI; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Aittokallio TA; Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Ramos PM; Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland.
  • Porkka KV; Department of Pathology, HUSLAB, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Mustjoki SM; HUS Diagnostic Center, HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Blood Cancer Discov ; 2(3): 238-249, 2021 May.
Article em En | MEDLINE | ID: mdl-34661156
ABSTRACT
In myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN), bone marrow (BM) histopathology is assessed to identify dysplastic cellular morphology, cellularity, and blast excess. Yet, other morphologic findings may elude the human eye. We used convolutional neural networks to extract morphologic features from 236 MDS, 87 MDS/MPN, and 11 control BM biopsies. These features predicted genetic and cytogenetic aberrations, prognosis, age, and gender in multivariate regression models. Highest prediction accuracy was found for TET2 [area under the receiver operating curve (AUROC) = 0.94] and spliceosome mutations (0.89) and chromosome 7 monosomy (0.89). Mutation prediction probability correlated with variant allele frequency and number of affected genes per pathway, demonstrating the algorithms' ability to identify relevant morphologic patterns. By converting regression models to texture and cellular composition, we reproduced the classical del(5q) MDS morphology consisting of hypolobulated megakaryocytes. In summary, this study highlights the potential of linking deep BM histopathology with genetics and clinical variables.

SIGNIFICANCE:

Histopathology is elementary in the diagnostics of patients with MDS, but its high-dimensional data are underused. By elucidating the association of morphologic features with clinical variables and molecular genetics, this study highlights the vast potential of convolutional neural networks in understanding MDS pathology and how genetics is reflected in BM morphology. See related commentary by Elemento, p. 195.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Doenças Mieloproliferativas-Mielodisplásicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Doenças Mieloproliferativas-Mielodisplásicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article